N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine

C142H133N39O10S — CID 160535201

About N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine

N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine (PubChem CID 160535201) has the molecular formula C142H133N39O10S and a molecular weight of 2577.96 g/mol. Its IUPAC name is N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine.

Molecular Properties

• Compound Name: N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine
• PubChem CID: 160535201
• Molecular Formula: C142H133N39O10S
• Molecular Weight: 2577.96 g/mol
• Exact Mass: 2576.08
• IUPAC Name: N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine
• SMILES: C1=NCc2cc(-c3cn4ccnc4c(Nc4ccc5c(c4)OCC4CN(c6ccccc6)CCN54)n3)ccc21.C1=NCc2cc(-c3cn4ccnc4c(Nc4ccc5c(c4)OCC4CN(c6ccccn6)CCN54)n3)ccc21.CN(CCN(C)c1ncc(C(=O)NO)cn1)c1ccc(Nc2nc(-c3ccc4c(c3)CN=C4)cn3ccnc23)cc1.CN(CCOCCC(=O)NO)c1ccc(Nc2nc(-c3ccc4c(c3)CN=C4)cn3ccnc23)cc1.CS(=O)(=O)N1CCN2c3ccc(Nc4nc(-c5ccc6c(c5)CN=C6)cn5ccnc45)cc3OCC2C1
• InChI: InChI=1S/C31H27N7O.C30H26N8O.C29H28N10O2.C26H25N7O3S.C26H27N7O3/c1-2-4-25(5-3-1)36-12-13-38-26(18-36)20-39-29-15-24(8-9-28(29)38)34-30-31-33-10-11-37(31)19-27(35-30)21-6-7-22-16-32-17-23(22)14-21;1-2-8-32-28(3-1)36-11-12-38-24(17-36)19-39-27-14-23(6-7-26(27)38)34-29-30-33-9-10-37(30)18-25(35-29)20-4-5-21-15-31-16-22(21)13-20;1-37(11-12-38(2)29-32-16-22(17-33-29)28(40)36-41)24-7-5-23(6-8-24)34-26-27-31-9-10-39(27)18-25(35-26)19-3-4-20-14-30-15-21(20)13-19;1-37(34,35)32-8-9-33-21(14-32)16-36-24-11-20(4-5-23(24)33)29-25-26-28-6-7-31(26)15-22(30-25)17-2-3-18-12-27-13-19(18)10-17;1-32(11-13-36-12-8-24(34)31-35)22-6-4-21(5-7-22)29-25-26-28-9-10-33(26)17-23(30-25)18-2-3-19-15-27-16-20(19)14-18/h1-11,14-16,19,26H,12-13,17-18,20H2,(H,34,35);1-10,13-15,18,24H,11-12,16-17,19H2,(H,34,35);3-10,13-14,16-18,41H,11-12,15H2,1-2H3,(H,34,35)(H,36,40);2-7,10-12,15,21H,8-9,13-14,16H2,1H3,(H,29,30);2-7,9-10,14-15,17,35H,8,11-13,16H2,1H3,(H,29,30)(H,31,34)
• InChIKey: QWBHRTFUZJECQA-UHFFFAOYSA-N
• XLogP: 19.60
• TPSA: 510.45 Ų
• H-Bond Donors: 9
• H-Bond Acceptors: 46
• Rotatable Bonds: 31
• Heavy Atoms: 192
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2577.96
LogP ≤ 5	19.60
H-Bond Donors ≤ 5	9
H-Bond Acceptors ≤ 10	46

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine?

The IUPAC name of N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine (CID 160535201) is N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine.

What is the SMILES notation for N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine?

The canonical SMILES for N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine is C1=NCc2cc(-c3cn4ccnc4c(Nc4ccc5c(c4)OCC4CN(c6ccccc6)CCN54)n3)ccc21.C1=NCc2cc(-c3cn4ccnc4c(Nc4ccc5c(c4)OCC4CN(c6ccccn6)CCN54)n3)ccc21.CN(CCN(C)c1ncc(C(=O)NO)cn1)c1ccc(Nc2nc(-c3ccc4c(c3)CN=C4)cn3ccnc23)cc1.CN(CCOCCC(=O)NO)c1ccc(Nc2nc(-c3ccc4c(c3)CN=C4)cn3ccnc23)cc1.CS(=O)(=O)N1CCN2c3ccc(Nc4nc(-c5ccc6c(c5)CN=C6)cn5ccnc45)cc3OCC2C1.

What is the InChIKey of N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine?

The InChIKey is QWBHRTFUZJECQA-UHFFFAOYSA-N. The full InChI is InChI=1S/C31H27N7O.C30H26N8O.C29H28N10O2.C26H25N7O3S.C26H27N7O3/c1-2-4-25(5-3-1)36-12-13-38-26(18-36)20-39-29-15-24(8-9-28(29)38)34-30-31-33-10-11-37(31)19-27(35-30)21-6-7-22-16-32-17-23(22)14-21;1-2-8-32-28(3-1)36-11-12-38-24(17-36)19-39-27-14-23(6-7-26(27)38)34-29-30-33-9-10-37(30)18-25(35-29)20-4-5-21-15-31-16-22(21)13-20;1-37(11-12-38(2)29-32-16-22(17-33-29)28(40)36-41)24-7-5-23(6-8-24)34-26-27-31-9-10-39(27)18-25(35-26)19-3-4-20-14-30-15-21(20)13-19;1-37(34,35)32-8-9-33-21(14-32)16-36-24-11-20(4-5-23(24)33)29-25-26-28-6-7-31(26)15-22(30-25)17-2-3-18-12-27-13-19(18)10-17;1-32(11-13-36-12-8-24(34)31-35)22-6-4-21(5-7-22)29-25-26-28-9-10-33(26)17-23(30-25)18-2-3-19-15-27-16-20(19)14-18/h1-11,14-16,19,26H,12-13,17-18,20H2,(H,34,35);1-10,13-15,18,24H,11-12,16-17,19H2,(H,34,35);3-10,13-14,16-18,41H,11-12,15H2,1-2H3,(H,34,35)(H,36,40);2-7,10-12,15,21H,8-9,13-14,16H2,1H3,(H,29,30);2-7,9-10,14-15,17,35H,8,11-13,16H2,1H3,(H,29,30)(H,31,34).

What are the key properties of N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine?

N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine has a molecular weight of 2577.96 g/mol, XLogP of 19.60, 31 rotatable bonds, 9 hydrogen bond donors, and 46 hydrogen bond acceptors.

Where does this data come from?

All data for N-hydroxy-3-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethoxy]propanamide;N-hydroxy-2-[2-[4-[[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]amino]-N-methylanilino]ethyl-methylamino]pyrimidine-5-carboxamide;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-methylsulfonyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-phenyl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine;N-[6-(3H-isoindol-5-yl)imidazo[1,2-a]pyrazin-8-yl]-3-pyridin-2-yl-2,4,4a,5-tetrahydro-1H-pyrazino[2,1-c][1,4]benzoxazin-8-amine is sourced from PubChem (CID 160535201), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).